Endometrial Carcinoma
97
19
35
36
Key Insights
Highlights
Success Rate
86% trial completion
Published Results
15 trials with published results (15%)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
6.2%
6 terminated out of 97 trials
85.7%
-0.8% vs benchmark
5%
5 trials in Phase 3/4
42%
15 of 36 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 36 completed trials
Clinical Trials (97)
Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical Cancer
A Study of Sacituzumab Govitecan (IMMU-132) in Endometrial Carcinoma
Non-Invasive Identification of Endometrial Cancer/Endometrial Atypical Hyperplasia With an AI-Based Classifier Applied to Transvaginal Ultrasound in Patients With Post-Menopausal Bleeding
Weight Management Plus Megestrol Acetate in Early-stage Endometrioid Carcinoma
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
Megestrol Acetate With or Without Pterostilbene in Treating Patients With Endometrial Cancer Undergoing Hysterectomy
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Combination Chemotherapy of Paclitaxel and Carboplatin With or Without Anthracycline as Aneo Adjuvant Treatment in Advanced Endometrial Carcinoma
Pelvic Floor Dysfunction and Quality of Life in Uterine Cancer Survivors
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
GYN-AIDE: Gynecologic Oncology Navigation Through AI-Driven Education
Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01)
Endometrial Carcinoma: Comparison of Surgical Approaches (Laparoscopy vs Laparotomy)
Changes in Pelvic Health, Sexual Function, and Quality of Life in Women With Pelvic Cancer Undergoing Radiation Therapy
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
AssociatiNG Bevacizumab bEmarituzumab for GynecoLogIcal CAncer
Infertility Survey Among Reproductive Age Women With Gynecological and Breast Cancer
Acceptability of Testing DNA Markers in Vaginal Fluid for the Detection of Endometrial Cancer
Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction